Recently an advisory committee has advised FDA to withdraw its support to market the drug, Calcitonin salmon, which is used to treat osteoporosis in postmenopausal women, after reviewing the risk factors and benefits of the drug.
Calcitonin salmon, commonly available as a nasal spray, is a synthetic equivalent of calcitonin hormone naturally found in salmon fish. Calcitonin salmon is said to prevent bone fracture and help increase bone density.
Lifestyle And Osteoporosis
Encyclopedia section of medindia briefly explains about Lifestyle and Osteoporosis
Advertisement
The panel after reviewing more than 20 clinical trials found that the risk of cancer was consistent in most of the studies. It was also noted that the drug was not very efficient in preventing bone fractures.
Although the risk of cancer was not very profound, the poor efficacy of the drug led the panel members to vote 9-12 against the continued use of the drug.
![Screening for Osteoporosis]( "Screening for Osteoporosis")
The risk of suffering from osteoporotic fractures is 30-50% in women and 15 to 30% in men. Osteoporosis screening is currently recommended for women only.
However, the drug is beneficial for short term-treatment and for patients who are allergic to other alternate drugs.
The committee members also voted 20-1 that companies developing new Calcitonin salmon products must prove the efficiency of the drug in preventing fractures.
FDA is yet to make its decision following the report of the review committee.
Source: Medindia
Screening for Osteoporosis
The risk of suffering from osteoporotic fractures is 30-50% in women and 15 to 30% in men. Osteoporosis screening is currently recommended for women only.
Advertisement
However, the drug is beneficial for short term-treatment and for patients who are allergic to other alternate drugs.
The committee members also voted 20-1 that companies developing new Calcitonin salmon products must prove the efficiency of the drug in preventing fractures.
FDA is yet to make its decision following the report of the review committee.
Source: Medindia
Study: Oral Calcitonin Tablet is Safe and Effective
Oral recombinant salmon calcitonin tablet is safe and effective for the treatment of postmenopausal osteoporosis, reveals Phase III ORACAL trial study of OSTORA.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
